ganaxolone

Other names: 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one, 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone, 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone, 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one, (3alpha,5alpha)-3-Hydroxy-3-methylpregnan-20-one, 3α-hydroxy-3β-methyl-5α-pregnan-20-one, pregnan-20-one, 3-hydroxy-3-methyl-, (3a,5a)-, Ztalmy

Classifications: 6000

Reasons for prohibition: - DEA Controlled Substance List: Schedule V (source)

References:

Reason: Controlled substance: Schedule V

Searchable name: ganaxolone

GUID: e38c2a73-0d19-466e-b098-b1fd068f1e02

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1710173731, "_nanoseconds": 890000000}